SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: zakaran who wrote (1009)10/4/2000 1:01:59 PM
From: Ian@SI  Read Replies (1) of 1321
 
One no-name broker downgraded the stock this morning. Later in the day, Yorkton upgraded to Strong Buy with a price target of $134Cdn.

I took advantage of today's action to have an early Xmas bonus - about $55K Cdn in Option premiums. I'd like to thank Mr. NoName for the opportunity presented. :-)

Ian.

++++++++++++++++++++

10/04 9:52 QLT Inc. Cut to `Hold' at Leerink Swann & Co By Donna Mcdonald

Princeton, New Jersey, Oct. 4 (Bloomberg Data) -- QLT Inc. (QLTI US) was downgraded to ``hold'' from ``speculative buy'' by analyst Robert H. Uhl at Leerink Swann & Co.

_____________

10/04 11:16
QLT Raised to `Strong Buy' at Yorkton Securities QLT Inc. (QLT CN) was raised to ``strong buy'' from ``accumulate'' by analyst Ezra S. Lwowski at Yorkton Securities. The 12-to-18-month target price is C$134.00 per share.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext